---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-26-108779"
form_type: "8-K"
ticker: "BJDX"
cik: "0001704287"
company_name: "Bluejay Diagnostics, Inc."
filed_at: "2026-10-13T13:09:40+00:00"
generated_at: "2026-10-13T13:11:04.657498+00:00"
event_type: "other_material"
sentiment: "positive"
materiality_score: 0.45
calibrated_materiality_score: 0.45
confidence: "high"
source: SEC EDGAR
---

# Bluejay completes Toray manufacturing-site milestone ahead of Oct 23 deadline

## Summary
- Bluejay formally notified Toray Industries it substantially completed establishment of a Symphony cartridge manufacturing site, ahead of the October 23, 2026 contractual deadline.
- Manufacturing split across SanyoSeiko Co., Ltd. in Japan (the site under the Toray agreement) and ALURIS Sciences, formerly Argonaut Manufacturing Services, in the U.S.
- Symphony IL-6 Test, the first product candidate, is not FDA cleared or approved and remains limited to investigational use in the U.S.; no financial terms disclosed.
- Regulatory path runs through the SYMON studies: SYMON-I (NCT06181604), pivotal SYMON-II (NCT06654895) to support a 510(k), and SYMON-III (NCT07425587).

## SEC filing metadata
- accession: 0001213900-26-108779
- form_type: 8-K
- ticker: BJDX
- cik: 0001704287
- company_name: Bluejay Diagnostics, Inc.
- filed_at: 2026-10-13T13:09:40+00:00
- event_type: other_material
- sentiment: positive
- materiality_score: 0.45
- calibrated_materiality_score: 0.45
- confidence: high
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1704287/000121390026108779/0001213900-26-108779-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1704287/000121390026108779/ea0308401-8k_bluejay.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-26-108779
- JSON: https://secwatch.observer/filing/0001213900-26-108779.json
- Plain text: https://secwatch.observer/filing/0001213900-26-108779.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.